Xiaohui Ma
16Patents
1h-index
69Co-inventors
53Inventor score
Filing activity: Jun 26, 2012 → Jan 28, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10300030B2 | Traditional Chinese medicine composition | Human Necessities | 1 | Active |
| US10071989B2 | Substituted cinnamamide derivative, preparation method and use thereof | Chemistry; Metallurgy | 1 | Active |
| US10626077B2 | Salvianolic acid compound T, preparation method therefor, and use thereof | Chemistry; Metallurgy | 1 | Active |
| US10507197B2 | Pharmaceutical composition containing silibinin | Emerging Cross-Sectional Technologies | 0 | Active |
| US11491173B2 | Pharmaceutical composition and application thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US10307396B2 | Pharmaceutical composition containing silybin, VE and L-carnitine | Emerging Cross-Sectional Technologies | 0 | Active |
| US11318112B2 | Pharmaceutical composition containing silybin and ve | Emerging Cross-Sectional Technologies | 0 | Active |
| US12090138B2 | Pharmaceutical composition containing silybin and VE | Emerging Cross-Sectional Technologies | 0 | Active |
| US10874636B2 | Application of substituted cinnamamide derivatives in preparation of anti-anxiety medication | Chemistry; Metallurgy | 0 | Active |
| US10376490B2 | Pharmaceutical composition containing silybin | Emerging Cross-Sectional Technologies | 0 | Active |
| US10307395B2 | Pharmaceutical composition containing silybin and L-carnitine | Emerging Cross-Sectional Technologies | 0 | Active |
| US9889093B2 | Application of andrographolide in the preparation of a pharmaceutical for treatment of inflammatory bowel disease, andrographolide enteric targeting micropellet, and method for preparation thereof | Performing Operations; Transporting | 0 | Active |
| US10376491B2 | Pharmaceutical composition containing silibinin and pueraria root extract | Emerging Cross-Sectional Technologies | 0 | Active |
| US12152059B2 | Method of treating nash using a long-acting mutant human fibroblast growth factor | Human Necessities | 0 | Active |
| US11655308B2 | HM-3 fusion protein and application thereof | Chemistry; Metallurgy | 0 | Active |
| US11098065B2 | Preparation method of an energetic coordination compound with 5-methyltetrazole | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.